Local Institution - 0032

London EC1A 7BE

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab — Completed